Avitide, LLC, a Repligen Company

Avitide, a Repligen Company, discovers, develops, manufactures and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry. Avitide’s proprietary AVIPure™ affinity ligand portfolio sets the standard for precise affinity separations and consistent robust performance for its high-valued chromatographic products. Avitide develops these technologies with an industry-leading 3-month, concept to resin delivery service timeline that enables industry biopharmaceutical manufacturers and contract developers to achieve faster bioprocess development timelines, improved process economics, predictable scalability, and enable next-generation integrated continuous downstream processing. Avitide’s commercial resin manufacturing and supply operates under an ISO 9001:2015 quality management system and has been successfully audited for its quality systems and continuity of supply plan for its affinity chromatography products. Avitide has successfully deployed affinity purification technologies towards an array of biological molecules including enzymes, bispecific antibodies, therapeutic scaffolds, growth factors, hormones, insulins, blood factors, Fcfusions, cell-based therapies, vaccines, and gene therapy viral vectors. For more information, visit www.avitide.com.

Website

http://www.avitide.com

External link for Avitide, LLC, a Repligen Company

Industry

Biotechnology Research

Company size

11-50 employees

Headquarters

Lebanon, New Hampshire

Type

Public Company

Founded

2012

Specialties

Biopharmaceutical Purification, Affinity Purification, Vaccine purification, and Biologics Purification